Cite

HARVARD Citation

    Maurer, M. et al. (2022). Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group. Circulation. pp. e009038-. [Online]. 
  
Back to record